Back to search
FDAFDA · Food and drugs·Recall number D-0388-2024

Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30.

Published March 20, 2024 · Recall initiated: February 9, 2024

Summary

FDA records drug Class II recall D-0388-2024, published March 20, 2024 and initiated February 9, 2024. Recalling firm: Micro Labs Limited; Status: Terminated; Reported quantity: 118,080 bottles; Lot: Lot #s: SFBG024, SFBG025, Exp. 05/31/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications: Out of specification for blend uniformity.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Micro Labs Limited
Distributor
Puerto Rico, TN, RI
Lot
Lot #s: SFBG024, SFBG025, Exp. 05/31/2024
Risk classification
Class II
Area (FDA)
drug
Country
India

Related recalls

Questions about this recall

Was Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30. recalled?

Yes. FDA published recall D-0388-2024 on March 20, 2024. Reported hazard: Failed Stability Specifications: Out of specification for blend uniformity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter